ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0QSS Phaxiam Therapeutics

71.025
0.00 (0.00%)
May 20 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 44.97M195.26M167.84M118.55M80.4M66.77M45.81M51.31M
Total Current Assets 42.53M191.57M149.91M81.58M49.63M40.05M42.63M16.22M
Cash and Equivalents 37.65M185.53M134.37M73.17M44.45M33.7M38.79M10.47M
Total Non-Current Assets 35.64M181.42M145.6M85.56M26.54M22.85M23.49M25.61M
Total Liabilities 9.33M13.84M22.24M32.99M53.86M43.92M22.32M25.7M
Total Current Liabilities 6.35M11.61M20.65M19.88M29.35M20.01M11.68M15.27M
Total Non-Current Liabilities 5.8M4.26M2.83M14.43M48.09M47.31M20.87M19.81M
Total Equity 35.64M181.42M145.6M85.56M26.54M22.85M23.49M25.61M
Common Equity 873k1.79M1.79M1.79M2.01M3.1M3.1M6.08M
Retained Earnings -21.91M-33.53M-38.22M-62.66M-73.3M-53.8M-227k-23.49M

Your Recent History

Delayed Upgrade Clock